Literature DB >> 14729876

Expression of MAL2, an integral protein component of the machinery for basolateral-to-apical transcytosis, in human epithelia.

Mónica Marazuela1, Agustín Acevedo, María Angeles García-López, Magdalena Adrados, María C de Marco, Miguel A Alonso.   

Abstract

MAL2, an integral membrane protein of the MAL family, is an essential component of the machinery necessary for the indirect transcytotic route of apical transport in human hepatoma HepG2 cells. To characterize the range of human epithelia that use MAL2-mediated pathways of transport, we carried out an immunohistochemical survey of normal tissues using a monoclonal antibody specific to the MAL2 protein. MAL2 expression was detected in specific types of normal epithelial cells throughout the respiratory system, the gastrointestinal and genitourinary tracts, in exocrine and endocrine glands, and in hepatocytes. Many different types of specialized secretory cells, either organized in discrete clusters (e.g., endocrine cells in the pancreas) or in endocrine glands (e.g., prostate), were also positive for MAL2. In addition to epithelial cells, peripheral neurons, mast cells, and dendritic cells were found to express MAL2. For comparison with normal epithelial tissue, different types of renal carcinoma were also analyzed, revealing alterations in MAL2 expression/distribution dependent on the particular histological type of the tumor. Our results allow the prediction of the existence of MAL2-based trafficking pathways in specific cell types and suggest applications of the anti-MAL2 antibody for the characterization of neoplastic tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729876     DOI: 10.1177/002215540405200212

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  13 in total

1.  MAL2 selectively regulates polymeric IgA receptor delivery from the Golgi to the plasma membrane in WIF-B cells.

Authors:  Julie G In; Pamela L Tuma
Journal:  Traffic       Date:  2010-05-07       Impact factor: 6.215

2.  Association Mining Identifies MAL2 as a Novel Tumor Suppressor in Colorectal Cancer.

Authors:  Kailai Wang; Yanmei Yang; Shu Zheng; Wangxiong Hu
Journal:  Onco Targets Ther       Date:  2022-07-09       Impact factor: 4.345

3.  Single-cell analyses reveal early thymic progenitors and pre-B cells in zebrafish.

Authors:  Sara A Rubin; Chloé S Baron; Cecilia Pessoa Rodrigues; Madeleine Duran; Alexandra F Corbin; Song P Yang; Cole Trapnell; Leonard I Zon
Journal:  J Exp Med       Date:  2022-08-08       Impact factor: 17.579

4.  Exogenous MAL reroutes selected hepatic apical proteins into the direct pathway in WIF-B cells.

Authors:  Sai Prasad Ramnarayanan; Christina A Cheng; Maria Bastaki; Pamela L Tuma
Journal:  Mol Biol Cell       Date:  2007-05-09       Impact factor: 4.138

5.  Effects of prenatal tobacco exposure on gene expression profiling in umbilical cord tissue.

Authors:  Naveed Hussain; Winfried Krueger; Jonathan Covault; Stephen Walsh; Henry R Kranzler; Cheryl Oncken
Journal:  Pediatr Res       Date:  2008-08       Impact factor: 3.756

6.  Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.

Authors:  Thiruvengadam Arumugam; Vijaya Ramachandran; Keith F Fournier; Huamin Wang; Lauren Marquis; James L Abbruzzese; Gary E Gallick; Craig D Logsdon; David J McConkey; Woonyoung Choi
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

7.  Clustering and lateral concentration of raft lipids by the MAL protein.

Authors:  Lee Goldstein Magal; Yakey Yaffe; Jeanne Shepshelovich; Juan Francisco Aranda; Maria del Carmen de Marco; Katharina Gaus; Miguel Angel Alonso; Koret Hirschberg
Journal:  Mol Biol Cell       Date:  2009-06-24       Impact factor: 4.138

8.  MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.

Authors:  Yuanzhang Fang; Lifei Wang; Changlin Wan; Yifan Sun; Kevin Van der Jeught; Zhuolong Zhou; Tianhan Dong; Ka Man So; Tao Yu; Yujing Li; Haniyeh Eyvani; Austyn B Colter; Edward Dong; Sha Cao; Jin Wang; Bryan P Schneider; George E Sandusky; Yunlong Liu; Chi Zhang; Xiongbin Lu; Xinna Zhang
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

9.  Interaction of PLP with GFP-MAL2 in the human oligodendroglial cell line HOG.

Authors:  Raquel Bello-Morales; Marta Pérez-Hernández; María Teresa Rejas; Fuencisla Matesanz; Antonio Alcina; José Antonio López-Guerrero
Journal:  PLoS One       Date:  2011-05-09       Impact factor: 3.240

10.  LncRNA ST8SIA6-AS1 Promotes Cholangiocarcinoma Progression by Suppressing the miR-145-5p/MAL2 Axis.

Authors:  Junchuang He; Hongxian Yan; Sidong Wei; Guoyong Chen
Journal:  Onco Targets Ther       Date:  2021-05-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.